menu search

Drug/biotech stocks' q4 earnings on feb 24: mrna, ebs & more

Let us take a look at five biotech/drug companies, namely, MRNA, EDIT, VIR, EBS and AERI, which are due to release their quarterly results on Feb 24....

February 23, 2022, 1:06 pm

Palo alto is leading the nasdaq higher, but 1 biotech is getting crushed wednesday

Investors are trying to take a longer-term view on the geopolitical situation....

February 23, 2022, 9:01 am

Palo alto is leading the nasdaq higher, but 1 biotech is getting crushed wednesday

Investors are trying to take a longer-term view on the geopolitical situation....

February 23, 2022, 9:01 am

Palo alto is leading the nasdaq higher, but 1 biotech is getting crushed wednesday

Investors are trying to take a longer-term view on the geopolitical situation....

February 23, 2022, 9:01 am

Biocept outlines how its cnside cerebrospinal fluid assay could improve treatment options for brain cancers

Biocept Inc (NASDAQ:BIOC) (Biocept Inc (NASDAQ:BIOC)) has highlighted how its CNSide cerebrospinal fluid (CSF) assay could improve the treatment optio...

February 23, 2022, 8:07 am

Biocept outlines how its cnside cerebrospinal fluid assay could improve treatment options for brain cancers

Biocept Inc (NASDAQ:BIOC) (Biocept Inc (NASDAQ:BIOC)) has highlighted how its CNSide cerebrospinal fluid (CSF) assay could improve the treatment optio...

February 23, 2022, 8:07 am

Biocept outlines how its cnside cerebrospinal fluid assay could improve treatment options for brain cancers

Biocept Inc (NASDAQ:BIOC) (Biocept Inc (NASDAQ:BIOC)) has highlighted how its CNSide cerebrospinal fluid (CSF) assay could improve the treatment optio...

February 23, 2022, 8:07 am

Verve therapeutics to present at the cowen 42nd annual healthcare conference

CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascula...

February 23, 2022, 6:30 am

Verve therapeutics to present at the cowen 42nd annual healthcare conference

CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascula...

February 23, 2022, 6:30 am

Verve therapeutics to present at the cowen 42nd annual healthcare conference

CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascula...

February 23, 2022, 6:30 am

Struggling biotech name to report earnings after the close

Halozyme Therapeutics Inc (NASDAQ:HALO) is gearing up for its fourth-quarter earnings report, due out after the close today, in which the company is e...

February 22, 2022, 2:34 pm

Struggling biotech name to report earnings after the close

Halozyme Therapeutics Inc (NASDAQ:HALO) is gearing up for its fourth-quarter earnings report, due out after the close today, in which the company is e...

February 22, 2022, 2:34 pm

Struggling biotech name to report earnings after the close

Halozyme Therapeutics Inc (NASDAQ:HALO) is gearing up for its fourth-quarter earnings report, due out after the close today, in which the company is e...

February 22, 2022, 2:34 pm

Drug/biotech stocks' q4 earnings on feb 23: bmrn, bhc & more

Let us take a look at five drug/biotech companies, namely, BMRN, CLVS, TBPH, BHC and GBT, which are due...

February 22, 2022, 1:05 pm

Drug/biotech stocks' q4 earnings on feb 23: bmrn, bhc & more

Let us take a look at five drug/biotech companies, namely, BMRN, CLVS, TBPH, BHC and GBT, which are due...

February 22, 2022, 1:05 pm

Drug/biotech stocks' q4 earnings on feb 23: bmrn, bhc & more

Let us take a look at five drug/biotech companies, namely, BMRN, CLVS, TBPH, BHC and GBT, which are due...

February 22, 2022, 1:05 pm

2 reasons to buy moderna, and 1 reason to sell

The story for this biotech is far from over -- but its path ahead may be more complicated....

February 22, 2022, 11:21 am

2 reasons to buy moderna, and 1 reason to sell

The story for this biotech is far from over -- but its path ahead may be more complicated....

February 22, 2022, 11:21 am

2 reasons to buy moderna, and 1 reason to sell

The story for this biotech is far from over -- but its path ahead may be more complicated....

February 22, 2022, 11:21 am

Pds biotechnology: versamune platform targeting hpv-associated cancers

PDS Biotechnology: Versamune Platform Targeting HPV-Associated Cancers...

February 21, 2022, 11:52 pm


Search within

Pages Search Results: